Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis
Abstract Corticosteroids may produce a paradoxical worsening of myasthenia gravis (MG) symptoms within the first weeks of treatment. We therefore wanted to assess the hypothesis that a prior infusion of intravenous immunoglobulin (IVIG) may have a protective effect. Our primary objectives were to sh...
Enregistré dans:
Auteurs principaux: | Laura Díez-Porras, Christian Homedes, Maria Antonia Alberti, Valentina Vélez-Santamaría, Carlos Casasnovas |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/242967baf4764d01abfbcf9b81b6a5e2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Profound olfactory dysfunction in myasthenia gravis.
par: Fidias E Leon-Sarmiento, et autres
Publié: (2012) -
Fetal Surveillance in Pregnancies with Myasthenia Gravis
par: Brîndușa Ana Cimpoca-Raptis, et autres
Publié: (2021) -
PLASMAPHERESIS IN THE TREATMENT OF MYASTHENIA GRAVIS: OUTCOME AND COMPLICATIONS
par: Maryam Abbas, et autres
Publié: (2021) -
Frontalis sling procedure for ocular myasthenia gravis
par: Isogai N, et autres
Publié: (2012) -
Current and emerging therapies for the treatment of myasthenia gravis
par: Renato Mantegazza, et autres
Publié: (2011)